Cargando…
Casodex treatment induces hypoxia-related gene expression in the LNCaP prostate cancer progression model
BACKGROUND: The changes in gene expression profile as prostate cancer progresses from an androgen-dependent disease to an androgen-independent disease are still largely unknown. METHODS: We examined the gene expression profile in the LNCaP prostate cancer progression model during chronic treatment w...
Autores principales: | Rothermund, Christy A, Gopalakrishnan, Velliyur K, Eudy, James D, Vishwanatha, Jamboor K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1079894/ https://www.ncbi.nlm.nih.gov/pubmed/15790403 http://dx.doi.org/10.1186/1471-2490-5-5 |
Ejemplares similares
-
Nuclear annexin II negatively regulates growth of LNCaP cells and substitution of ser 11 and 25 to glu prevents nucleo-cytoplasmic shuttling of annexin II
por: Liu, Jie, et al.
Publicado: (2003) -
ADAMTS1 alters blood vessel morphology and TSP1 levels in LNCaP and LNCaP-19 prostate tumors
por: Gustavsson, Heléne, et al.
Publicado: (2010) -
Calcitriol and TO-901317 Interact in Human Prostate Cancer LNCaP Cells
por: Wang, Jing-Huan, et al.
Publicado: (2008) -
LNCaP Atlas: Gene expression associated with in vivo progression to castration-recurrent prostate cancer
por: Romanuik, Tammy L, et al.
Publicado: (2010) -
Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines
por: Vishwanatha, Jamboor K, et al.
Publicado: (2004)